NCT05277688View on ClinicalTrials.gov

Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2027

Conditions
Cervical Cancer
Interventions
DRUG

adjuvant concurrent chemoradiotherapy

concurrent chemotherapy: cisplatin（DDP） weekly, 40mg/m2, begin with radiation Drug: cisplatin（DDP） weekly; Intensity modulated radiotherapy (IMRT) is given five fractions per week at 1.8-2 Gy/fraction/day with total dose summed up to 45-50Gy.

RADIATION

radiotherapy

Intensity modulated radiotherapy (IMRT) is given five fractions per week at 1.8-2 Gy/fraction/day with total dose summed up to 45-50Gy.

Trial Locations (2)

200025

NOT_YET_RECRUITING

Ruijin Hospital, Shanghai jiaotong univestigy school of medicine, Shanghai

RECRUITING

Ruijin Hospital, Shanghai jiaotong univestigy school of medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER